The Khalifa University Center for Biotechnology (BTC) was established on 2 June 2015 to develop the University’s capabilities in training and research to respond to three of the six priority areas under the four pillars of the UAE 2021 vision. Without local effort in genome research, the targets set and the vision to develop a knowledge economy in bioscience and competencies in laboratory diagnostic practice is highly problematic. Since its foundation, the BTC has developed competencies in genomics and bioinformatics in collaboration with a plethora of external stakeholders.
In 2018, as the Center takes possession of a customized laboratory to provide a base to accelerate the process of discovery, its mandate is to improve the body of information on genetic predisposition to diseases that are common to the UAE population. In these new premises, the Center intends to add capabilities in functional biology, the third cog in the repertoire that is molecular biology. This strategic addition coincides with the consummation of a memorandum of understanding (MOU) with Al Ain Fertility Center. It will provide the capability to study the functional relevance of novel genetic associations that are identified. This addition will further expand BTC’s current network of local, regional and international collaborators.
